Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Renal sympathetic denervation: a novel intervention for resistant hypertension, insulin resistance, and sleep apnea.

Literature DB >> 21844486

Renal sympathetic denervation: a novel intervention for resistant hypertension, insulin resistance, and sleep apnea.

Brent M Egan.

Abstract

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：
Blood Glucose

Year: 2011 PMID： 21844486 PMCID： PMC3191492 DOI： 10.1161/HYPERTENSIONAHA.111.179101

Source DB: PubMed Journal: Hypertension ISSN： 0194-911X Impact factor: 10.190

× No keyword cloud information.

12 in total

1. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.

Authors: Felix Mahfoud; Markus Schlaich; Ingrid Kindermann; Christian Ukena; Bodo Cremers; Mathias C Brandt; Uta C Hoppe; Oliver Vonend; Lars C Rump; Paul A Sobotka; Henry Krum; Murray Esler; Michael Böhm
Journal: Circulation Date: 2011-04-25 Impact factor: 29.690

2. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors: Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal: Lancet Date: 2010-11-17 Impact factor: 79.321

Review 3. Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system.

Authors: Henry Krum; Paul Sobotka; Felix Mahfoud; Michael Böhm; Murray Esler; Markus Schlaich
Journal: Circulation Date: 2011-01-18 Impact factor: 29.690

4. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.

Authors: Adam Witkowski; Aleksander Prejbisz; Elżbieta Florczak; Jacek Kądziela; Paweł Śliwiński; Przemysław Bieleń; Ilona Michałowska; Marek Kabat; Ewa Warchoł; Magdalena Januszewicz; Krzysztof Narkiewicz; Virend K Somers; Paul A Sobotka; Andrzej Januszewicz
Journal: Hypertension Date: 2011-08-15 Impact factor: 10.190

5. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension.

Authors: Oded Friedman; T Douglas Bradley; Christopher T Chan; Robert Parkes; Alexander G Logan
Journal: Hypertension Date: 2010-11-08 Impact factor: 10.190

Review 6. Translational medicine: the antihypertensive effect of renal denervation.

Authors: Gerald F DiBona; Murray Esler
Journal: Am J Physiol Regul Integr Comp Physiol Date: 2009-12-02 Impact factor: 3.619

7. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors: David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal: Hypertension Date: 2008-04-07 Impact factor: 10.190

Review 8. Regulation of glucose transport in human skeletal muscle.

Authors: H A Koistinen; J R Zierath
Journal: Ann Med Date: 2002 Impact factor: 4.709

Review 9. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis.

Authors: Alastair J S Webb; Urs Fischer; Ziyah Mehta; Peter M Rothwell
Journal: Lancet Date: 2010-03-13 Impact factor: 79.321

10. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report.

Authors: K Gaddam; E Pimenta; S J Thomas; S S Cofield; S Oparil; S M Harding; D A Calhoun
Journal: J Hum Hypertens Date: 2009-12-17 Impact factor: 3.012

6 in total

Renal sympathetic denervation: a novel intervention for resistant hypertension, insulin resistance, and sleep apnea.

1. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.

2. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Review 3. Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system.

4. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea.

5. Relationship between overnight rostral fluid shift and obstructive sleep apnea in drug-resistant hypertension.

Review 6. Translational medicine: the antihypertensive effect of renal denervation.

7. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Review 8. Regulation of glucose transport in human skeletal muscle.

Review 9. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis.

10. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report.

1. Overview of resistant hypertension: A glimpse of the cardiologist's current standpoint.

2. Renal Sympathetic Denervation for Treatment of Hypertension.

3. Renal denervation therapy for resistant hypertension.

4. Renal denervation: a new treatment option in resistant arterial hypertension.

Review 5. Renal sympathetic denervation in the treatment of resistant hypertension.

Review 6. Percutaneous revascularization for ischemic nephropathy: the past, present, and future.